A Phase III Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18-multicenter,Investigator Initiated Clinical Trial
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Trafermin (Primary)
- Indications Ear disorders; Tympanic membrane perforation
- Focus Therapeutic Use
- 20 Dec 2016 Status changed from active, no longer recruiting to completed.
- 13 Sep 2016 New trial record